Jing-Jing Zhao Selected Research

Annexin A3

12/2020	Annexin A3 upregulates the infiltrated neutrophil-lymphocyte ratio to remodel the immune microenvironment in hepatocellular carcinoma.
8/2015	Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma.
2/2015	Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jing-Jing Zhao Research Topics

Disease

34	Neoplasms (Cancer) 08/2021 - 07/2010
15	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 09/2010
8	Atherosclerosis 12/2021 - 12/2015
6	Carcinogenesis 01/2019 - 10/2010
5	Neoplasm Metastasis (Metastasis) 01/2020 - 09/2014
4	Atherosclerotic Plaque (Atheroma) 12/2021 - 01/2016
4	Breast Neoplasms (Breast Cancer) 08/2021 - 10/2010
4	Inflammation (Inflammations) 01/2019 - 01/2016
3	Glioma (Gliomas) 01/2022 - 01/2018
3	Stroke (Strokes) 01/2021 - 12/2012
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 11/2017
3	Lymphatic Metastasis 01/2019 - 06/2014
3	Esophageal Squamous Cell Carcinoma 01/2018 - 10/2013
3	Liver Neoplasms (Liver Cancer) 09/2017 - 03/2011
3	Infections 01/2016 - 09/2010
3	Pain (Aches) 01/2014 - 11/2005
2	Melanoma (Melanoma, Malignant) 05/2022 - 01/2020
2	Wounds and Injuries (Trauma) 12/2021 - 01/2012
2	Spinal Cord Injuries (Spinal Cord Injury) 11/2021 - 12/2018
2	Atrial Fibrillation 01/2021 - 03/2016
2	Edema (Dropsy) 12/2020 - 01/2012
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 09/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2020
2	Coronary Disease (Coronary Heart Disease) 12/2019 - 12/2015
2	Stomach Neoplasms (Stomach Cancer) 01/2019 - 10/2010
2	Ischemic Stroke 04/2018 - 07/2013
2	Nasopharyngeal Carcinoma 01/2018 - 01/2018
2	Esophageal Neoplasms (Esophageal Cancer) 05/2016 - 10/2013
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Abscess 01/2022
1	Cardiotoxicity 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021
1	Eczema 02/2021
1	Drug Resistant Epilepsy 01/2021
1	Liposarcoma 01/2021
1	Seizures (Absence Seizure) 01/2021
1	Embolic Stroke 01/2021

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 08/2021 - 08/2014
9	Long Noncoding RNAIBA 01/2022 - 11/2016
9	CytokinesIBA 05/2020 - 07/2010
8	Biomarkers (Surrogate Marker)IBA 05/2020 - 10/2010
5	Pharmaceutical PreparationsIBA 01/2022 - 01/2016
5	Messenger RNA (mRNA)IBA 12/2019 - 03/2011
4	Biological ProductsIBA 01/2019 - 06/2014
3	Interleukin-17 (Interleukin 17)IBA 02/2021 - 10/2013
3	Annexin A3IBA 12/2020 - 02/2015
2	AlbuminsIBA 05/2022 - 03/2015
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2018
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 07/2020
2	pembrolizumabIBA 01/2021 - 01/2018
2	Capsules (Microcapsules)IBA 01/2021 - 03/2015
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2019 - 12/2018
2	Untranslated RNA (Noncoding RNA)IBA 07/2019 - 09/2018
2	InterferonsIBA 01/2019 - 10/2013
2	Antisense RNA (Anti-Sense RNA)IBA 01/2019 - 11/2016
2	Methylprednisolone FDA LinkGeneric 12/2018 - 09/2012
2	Caspase 3 (Caspase-3)IBA 09/2018 - 09/2010
2	HDL CholesterolIBA 01/2018 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 12/2015
2	AntigensIBA 11/2017 - 01/2017
2	InterleukinsIBA 01/2017 - 10/2013
2	oxidized low density lipoproteinIBA 01/2016 - 07/2013
2	CholesterolIBA 01/2016 - 01/2016
2	Protein Isoforms (Isoforms)IBA 10/2015 - 04/2015
1	130-nm albumin-bound paclitaxelIBA 05/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	liposomal doxorubicin (Doxil)FDA Link 01/2022
1	cupric sulfide (CuS)IBA 01/2022
1	Thymidine Monophosphate (TMP)IBA 12/2021
1	ErbB Receptors (EGF Receptor)IBA 11/2021
1	Small Interfering RNA (siRNA)IBA 08/2021
1	EnzymesIBA 08/2021
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 08/2021
1	human PRMT2 proteinIBA 08/2021
1	QuercetinIBA 02/2021
1	LuteolinIBA 02/2021
1	kaempferolIBA 02/2021
1	Mitogen-Activated Protein Kinase 14IBA 02/2021
1	Mahuang Lianqiao Chixiaodou DecoctionIBA 02/2021
1	wogoninIBA 02/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	toripalimabIBA 01/2021
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	HirudinsIBA 01/2021

Therapy/Procedure

17	Immunotherapy 01/2021 - 10/2013
15	Therapeutics 01/2021 - 10/2010
5	Drug Therapy (Chemotherapy) 01/2020 - 06/2014
3	Radiotherapy 01/2019 - 01/2017
2	Photothermal Therapy 01/2022 - 01/2017
2	Ligation 01/2021 - 07/2013
2	Aftercare (After-Treatment) 01/2020 - 11/2005
2	Chemoradiotherapy 01/2019 - 01/2018
2	Mastectomy (Mammectomy) 01/2019 - 06/2014
1	Lasers (Laser) 01/2022
1	Transplantation 12/2021
1	Secondary Prevention 01/2021